-
1دورية أكاديميةThe use of multiplex platforms for absolute and relative protein quantification of clinical material
المؤلفون: Lisa Christiansson, Satu Mustjoki, Bengt Simonsson, Ulla Olsson-Strömberg, Angelica S.I. Loskog, Sara M. Mangsbo
المصدر: EuPA Open Proteomics, Vol 3, Iss C, Pp 37-47 (2014)
مصطلحات موضوعية: Multiplex protein quantification, ELISA, Luminex, Somalogic, Meso Scale Discovery, Chronic myeloid leukemia, Genetics, QH426-470
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Lisa Christiansson, Stina Söderlund, Emma Svensson, Satu Mustjoki, Mats Bengtsson, Bengt Simonsson, Ulla Olsson-Strömberg, Angelica S I Loskog
المصدر: PLoS ONE, Vol 8, Iss 1, p e55818 (2013)
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Rüdiger Hehlmann, David Grimwade, Bengt Simonsson, Jane Apperley, Michele Baccarani, Tiziano Barbui, Giovanni Barosi, Renato Bassan, Marie C. Béné, Ute Berger, Thomas Büchner, Alan Burnett, Nicolas C.P. Cross, Theo J.M. de Witte, Hartmut Döhner, Hervé Dombret, Hermann Einsele, Georg Engelich, Robin Foà, Christa Fonatsch, Nicola Gökbuget, Elaine Gluckman, Alois Gratwohl, Francois Guilhot, Claudia Haferlach, Thorsten Haferlach, Michael Hallek, Jörg Hasford, Andreas Hochhaus, Dieter Hoelzer, Jean-Jaques Kiladjian, Boris Labar, Per Ljungman, Ulrich Mansmann, Dietger Niederwieser, Gert Ossenkoppele, José M. Ribera, Harald Rieder, Hubert Serve, Petra Schrotz-King, Miguel A. Sanz, Susanne Saußele
المصدر: Haematologica, Vol 96, Iss 1 (2011)
مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
-
4
المؤلفون: Srikanth Gajavelli, Loretta A. Williams, Mauricette Michallet, Ron Paquette, Irene DeGutis, Ruediger Hehlmann, Jorge E. Cortes, Teresa Zyczynski, Michael J. Mauro, Ginny P Sen, Carlo Gambacorti-Passerini, Bengt Simonsson, Stuart L. Goldberg
المساهمون: Hehlmann, R, Cortes, J, Zyczynski, T, Gambacorti-Passerini, C, Goldberg, S, Mauro, M, Michallet, M, Simonsson, B, Williams, L, Gajavelli, S, Degutis, I, Sen, G, Paquette, R
المصدر: American Journal of Hematology
مصطلحات موضوعية: Male, medicine.medical_specialty, Myeloid, medicine.drug_class, Respiratory Tract Diseases, Dasatinib, Antineoplastic Agents, Drug Administration Schedule, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Intolerances, MED/15 - MALATTIE DEL SANGUE, Internal medicine, Humans, Medicine, Molecular Targeted Therapy, Musculoskeletal Diseases, Prospective Studies, Hematologi, Prospective cohort study, Protein Kinase Inhibitors, Research Articles, Aged, Cancer och onkologi, Drug Substitution, business.industry, Disease Management, Myeloid leukemia, Imatinib, Hematology, Hematologic Diseases, United States, respiratory tract diseases, Europe, Pyrimidines, medicine.anatomical_structure, Nilotinib, Drug Resistance, Neoplasm, Cancer and Oncology, 030220 oncology & carcinogenesis, Leukemia, Myeloid, Chronic-Phase, Imatinib Mesylate, Female, business, Research Article, 030215 immunology, medicine.drug
وصف الملف: application/pdf; ELETTRONICO
-
5
المؤلفون: Martin Höglund, Fredrik Sandin, Bengt Simonsson, Leif Stenke
المصدر: Hematologic Malignancies ISBN: 9783030719128
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e02a3bb241b7ba0a0c9f9c0d077c13a7
https://doi.org/10.1007/978-3-030-71913-5_3 -
6
المؤلفون: Angelica Loskog, Satu Mustjoki, Johan Richter, Ulla Olsson-Strömberg, Lisa Christiansson, Stina Söderlund, Inger Persson, Bengt Simonsson, Henrik Hjorth-Hansen
المساهمون: Satu Mustjoki / Principal Investigator, Department of Medicine, Clinicum, Hematologian yksikkö, Department of Oncology
المصدر: Leukemia Research. 50:95-103
مصطلحات موضوعية: Male, Proteomics, 0301 basic medicine, Cancer Research, Myeloid, Angiogenesis, Dasatinib, Tyrosine kinase inhibitor, Pilot Projects, Tyrosine-kinase inhibitor, Th1, DASATINIB THERAPY, 0302 clinical medicine, hemic and lymphatic diseases, Hematology, Neovascularization, Pathologic, Chronic myeloid leukemia, CHRONIC MYELOGENOUS LEUKEMIA, Blood Proteins, Middle Aged, Protein-Tyrosine Kinases, 3. Good health, medicine.anatomical_structure, Oncology, GROWTH-HORMONE DEFICIENCY, 030220 oncology & carcinogenesis, Imatinib Mesylate, Female, Stem cell, STEM-CELLS, medicine.drug, Adult, medicine.medical_specialty, medicine.drug_class, BONE-MARROW, 3122 Cancers, Biology, IMATINIB, 03 medical and health sciences, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, medicine, COMPLETE MOLECULAR REMISSION, Humans, CHRONIC MYELOID-LEUKEMIA, Protein Kinase Inhibitors, Aged, Imatinib, Th1 Cells, medicine.disease, 030104 developmental biology, Immunology, T-CELLS, Cancer research, FOLLOW-UP, Chronic myelogenous leukemia
-
7
المؤلفون: Pascale Cony-Makhoul, Carlo Gambacorti-Passerini, Elza Lomaia, Ruediger Hehlmann, Bengt Simonsson, Michael J. Mauro, Aart Beeker, Mauricette Michallet, Eduardo Olavarria, Stuart L. Goldberg, Richard M. Hansen, Elisabetta Abruzzese, David Andorsky, Aimee Foreman, Jorge E. Cortes, Teresa Zyczynski, H. Jean Khoury, Ron Paquette
المساهمون: Goldberg, S, Cortes, J, Gambacorti-Passerini, C, Hehlmann, R, Khoury, H, Michallet, M, Paquette, R, Simonsson, B, Zyczynski, T, Foreman, A, Abruzzese, E, Andorsky, D, Beeker, A, Cony-Makhoul, P, Hansen, R, Lomaia, E, Olavarria, E, Mauro, M
المصدر: American Journal of Hematology
مصطلحات موضوعية: Oncology, Adult, Male, United State, medicine.medical_specialty, Pediatrics, Myeloid, media_common.quotation_subject, Biopsy, Protein Kinase Inhibitor, Comorbidity, Follow-Up Studie, 03 medical and health sciences, 0302 clinical medicine, Bone Marrow, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Routine clinical practice, Simplicity, Hematologi, Practice Patterns, Physicians', Protein Kinase Inhibitors, Selection (genetic algorithm), Research Articles, In Situ Hybridization, Fluorescence, media_common, Aged, Hematology, business.industry, Myeloid leukemia, Middle Aged, medicine.disease, United States, Europe, Leukemia, medicine.anatomical_structure, Treatment Outcome, 030220 oncology & carcinogenesis, Leukemia, Myeloid, Chronic-Phase, Female, Bone marrow, business, 030215 immunology, Follow-Up Studies, Research Article, Human
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ad2e6a3c4d932c21654f5abea0ec46
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-339738 -
8
المؤلفون: William V. Padula, Richard A. Larson, Stacie B. Dusetzina, Jane F. Apperley, Rudiger Hehlmann, Michele Baccarani, Ekkehard Eigendorff, Joelle Guilhot, Francois Guilhot, Francois-Xavier Mahon, Giovanni Martinelli, Jiri Mayer, Martin C. Müller, Dietger Niederwieser, Susanne Saussele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson, Rena M. Conti
المساهمون: Leuka, National Institute for Health Research, Padula, William V., Larson, Richard A., Dusetzina, Stacie B., Apperley, Jane F., Hehlmann, Rudiger, Baccarani, Michele, Eigendorff, Ekkehard, Guilhot, Joelle, Guilhot, Francoi, Mahon, Francois Xavier, Martinelli, Giovanni, Mayer, Jiri, Müller, Martin C., Niederwieser, Dietger, Saussele, Susanne, Schiffer, Charles A., Silver, Richard T., Simonsson, Bengt, Conti, Rena M.
المصدر: JNCI Journal of the National Cancer Institute
مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Medicin och hälsovetenskap, Cost effectiveness, Cost-Benefit Analysis, Medical and Health Sciences, Tyrosine-kinase inhibitor, Antineoplastic Agent, 0302 clinical medicine, Protein-Tyrosine Kinase, Quality-Adjusted Life Year, hemic and lymphatic diseases, Practice Patterns, Physicians', health care economics and organizations, Medicine (all), Myeloid leukemia, Middle Aged, Protein-Tyrosine Kinases, Markov Chains, 3. Good health, Dasatinib, Treatment Outcome, 030220 oncology & carcinogenesis, Imatinib Mesylate, Female, Survival Analysi, Quality-Adjusted Life Years, Models, Econometric, medicine.drug, Human, United State, Adult, medicine.medical_specialty, medicine.drug_class, Protein Kinase Inhibitor, Antineoplastic Agents, Article, 03 medical and health sciences, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, medicine, Drugs, Generic, Humans, Oncology & Carcinogenesis, Cost-Benefit Analysi, neoplasms, Protein Kinase Inhibitors, Aged, business.industry, Imatinib, Markov Chain, medicine.disease, Survival Analysis, United States, 030104 developmental biology, Imatinib mesylate, Nilotinib, Immunology, business, 1112 Oncology And Carcinogenesis, Chronic myelogenous leukemia
وصف الملف: application/pdf; ELETTRONICO
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42698558a7334d55ab20503cad057adb
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-304522 -
9
المؤلفون: Gert J. Ossenkoppele, Dubravka Sertić, Perttu Koskenvesa, L.F. Casado, Doris Lindoerfer, F. Di Raimondo, Andrzej Hellmann, Andrija Bogdanovic, Verena S. Hoffmann, Irena Preloznik Zupan, Daniela Zackova, Laimonas Griskevicius, Fausto Castagnetti, Karel Indrak, Sonja Burgstaller, Martin Höglund, Michele Baccarani, Andrey Zaritskey, Ruediger Hehlmann, Joelle Guilhot, Paul Costeas, Anna G. Turkina, Sandra Lejniece, Tomasz Sacha, Richard E. Clark, Joerg Hasford, Andreas Hochhaus, Susanne Saussele, Zuzana Sninská, Gabriele Schubert-Fritschle, Hele Everaus, Gianantonio Rosti, Bengt Simonsson
المساهمون: Hoffmann, V.S, Baccarani, M., Hasford, J., Castagnetti, F., Di Raimondo, F., Casado, L.F., Turkina, A., Zackova, D., Ossenkoppele, G., Zaritskey, A., Höglund, M., Simonsson, B., Indrak, K., Sninska, Z., Sacha, T., Clark, R., Bogdanovic, A., Hellmann, A., Griskevicius, L., Schubert-Fritschle, G., Sertic, D., Guilhot, J., Lejniece, S., Zupan, I., Burgstaller, S., Koskenvesa, P., Everaus, H., Costeas, P., Lindoerfer, D., Rosti, G., Saussele, S., Hochhaus, A., Hehlmann, R., CCA - Cancer Treatment and quality of life, Hematology
المصدر: Leukemia, 31(3), 593-601. Nature Publishing Group
Hoffmann, V S, Baccarani, M, Hasford, J, Castagnetti, F, Di Raimondo, F, Casado, L F, Turkina, A, Zackova, D, Ossenkoppele, G, Zaritskey, A, Höglund, M, Simonsson, B, Indrak, K, Sninska, Z, Sacha, T, Clark, R, Bogdanovic, A, Hellmann, A, Griskevicius, L, Schubert-Fritschle, G, Sertic, D, Guilhot, J, Lejniece, S, Zupan, I, Burgstaller, S, Koskenvesa, P, Everaus, H, Costeas, P, Lindoerfer, D, Rosti, G, Saussele, S, Hochhaus, A & Hehlmann, R 2017, ' Treatment and outcome of 2904 CML patients from the EUTOS population-based registry ', Leukemia, vol. 31, no. 3, pp. 593-601 . https://doi.org/10.1038/leu.2016.246مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Cancer Research, Adolescent, Population, 03 medical and health sciences, European LeukemiaNet, Young Adult, 0302 clinical medicine, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Registries, education, Survival analysis, Aged, Aged, 80 and over, education.field_of_study, business.industry, Incidence (epidemiology), Incidence, Imatinib, Hematology, Middle Aged, Survival Analysis, 3. Good health, Surgery, Dasatinib, Clinical trial, Europe, Treatment Outcome, Anesthesiology and Pain Medicine, Oncology, Nilotinib, 030220 oncology & carcinogenesis, Population Surveillance, Female, business, 030215 immunology, medicine.drug, Follow-Up Studies
وصف الملف: STAMPA
-
10
المؤلفون: Fredrik Sandin, Bengt Simonsson, Martin Höglund
المصدر: Hematologic Malignancies ISBN: 9783319331973
مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, Relative survival, business.industry, Incidence (epidemiology), Population, Myeloid leukemia, Clinical trial, hemic and lymphatic diseases, Internal medicine, Epidemiology, medicine, In patient, education, business, Socioeconomic status
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bdcbbec2ba22dc30e3396e61b3461b59
https://doi.org/10.1007/978-3-319-33198-0_7